Medicamen Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 ,inter alia, to consider and approve the audited financial results (Standalone and Consolidated) for the quarter and year ended on March 31, 2026 and for recommendation of Final Divided for FY 2025-26 on Equity Shares of the Company.